Immune Check-Point Blockade as a Potential Therapeutic Strategy for Undifferentiated Malignancies

被引：0
作者：
Devereaux, Kelly [1 ]
Charville, Gregory [1 ]
Zhao, Shuchun [1 ]
Cherry, Athena [1 ]
van de Rijn, Matt [1 ]
Natkunam, Yasodha [1 ]
机构：
[1] Stanford Hlth Care, Stanford, CA USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1832
引用
收藏
页码：456A / 456A
页数：1
相关论文
共 50 条
  • [21] Targeted Interleukin 2 and synergy with immune check-point inhibitors
    Hutmacher-Berndt, Cornelia Deborah
    Neri, Dario
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Immunotherapy targeting immune check-point(s) in brain metastases
    Di Giacomo, Anna Maria
    Valente, Monica
    Covre, Alessia
    Danielli, Riccardo
    Maio, Michele
    CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 36 : 33 - 38
  • [23] IMMUNE CHECKPOINT BLOCKADE AS A POTENTIAL THERAPEUTIC TARGET: SURVEYING CNS MALIGNANCIES
    Heimberger, Amy
    Garber, Sarah
    Hashimoto, Yuuri
    Weathers, Shiao-Pei
    Xiu, Joanne
    Gatalica, Zoran
    Verhaak, Roel
    Zhou, Shouhao
    Fuller, Gregory
    Khasraw, Mustafa
    de Groot, John
    Reddy, Sandeep
    Spetzler, David
    NEURO-ONCOLOGY, 2016, 18 : 41 - 41
  • [24] CHEMOTHERAPY OF MALIGNANT PLEURAL MESOTHELIOMA DOES NOT PRECLUDE USE OF CHECK-POINT BLOCKADE
    Fontecedro, A. Curioni
    Cecconi, V.
    Bosco, E. Felley
    Schmitt-Opitz, I.
    Weder, W.
    Stahel, R. A.
    van den Broek, M.
    Tischler, V.
    ANNALS OF ONCOLOGY, 2015, 26
  • [25] Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
    Garber, Sarah T.
    Hashimoto, Yuuri
    Weathers, Shiao-Pei
    Xiu, Joanne
    Gatalica, Zoran
    Verhaak, Roel G. W.
    Zhou, Shouhao
    Fuller, Gregory N.
    Khasraw, Mustafa
    de Groot, John
    Reddy, Sandeep K.
    Spetzler, David
    Heimberger, Amy B.
    NEURO-ONCOLOGY, 2016, 18 (10) : 1357 - 1366
  • [26] Chemotherapy Plus Immune Check-Point Inhibitors in Metastatic Bladder Cancer
    Soares, Adriana
    Carmo, Rafael
    Rodrigues, Catarina
    Grilo, Ines Teles
    Grande, Enrique
    BLADDER CANCER, 2020, 6 (01) : 1 - 8
  • [27] MYOCARDITIS SECONDARY TO IMMUNE CHECK-POINT INHIBITORS: DIFFICULTIES IN ARRHYTHMIA MANAGEMENT
    Stringer, Bryan F.
    Kethireddy, Nikhila
    Rizkallah, Alain
    Darsaklis, Konstadina
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2694 - 2694
  • [28] Morphological spectrum of immune check-point inhibitor therapy-associated gastritis
    Johncilla, Melanie
    Grover, Shilpa
    Zhang, Xuchen
    Jain, Dhanpat
    Srivastava, Amitabh
    HISTOPATHOLOGY, 2020, 76 (04) : 531 - 539
  • [29] Immune-related adverse reactions as a result of therapy with check-point inhibitors
    Makowska, Joanna
    Lewandowska-Polak, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2018, 23 (01): : 2 - 6
  • [30] Neurological toxicity in cancer patients treated with immune check-point inhibitor therapy
    Reoma, Lauren
    Narayan, Ram
    Albert, Julie
    Gudlavalleti, Aashrai
    Smith, Bryan
    Schindler, Matthew
    Reich, Daniel
    Apolo, Andrea
    Karzai, Fatima
    Rajan, Arun
    Gulley, James
    Khan, Omar
    Nath, Avindra
    NEUROLOGY, 2019, 92 (15)
12345